Cutler Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Cutler Group’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-100	Closed	-$1K	–	5761
2020 Q3	$1K	Sell	100 -320	-76%	-$6.63K	﹤0.01%	4553
2020 Q2	$10K	Sell	420 -280	-40%	-$6.03K	﹤0.01%	2910
2020 Q1	$12K	Sell	700 -200	-22%	-$3.89K	﹤0.01%	2636
2019 Q4	$19K	Buy	+900	New	+$18.1K	﹤0.01%	2258
2019 Q1	–	Sell	-200	Closed	-$2K	–	5014
2018 Q4	$2K	Buy	+200	New	+$2.63K	﹤0.01%	3490
2018 Q3	–	Sell	-1,000	Closed	-$12K	–	4943
2018 Q2	$12K	Buy	+1,000	New	+$12.6K	﹤0.01%	2568

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Cutler Group's DRNA Position: Q4 2020 in Review

Cutler Group sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2020, closing a stake of 100 shares — an estimated $1K sold.

Cutler Group first reported a position in DRNA in Q2 2018 and held it in 6 quarters. The position peaked at $19K in Q4 2019. 173 funds tracked by Wall St. Rank hold DRNA as of Q4 2020.

Cutler Group reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Cutler Group sold 100 Dicerna Pharmaceuticals, Inc. shares in Q4 2020, an estimated $1K.
Cutler Group first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2018 and held it in 6 quarters.
Cutler Group's Dicerna Pharmaceuticals, Inc. position peaked at $19K in Q4 2019.
173 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2020.

Based on Cutler Group's 13F filing for Q4 2020, filed 21 Jan 2021.